BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND HOXC11, HOX3H, 3227, ENSG00000123388, O43248
7 results:

  • 1. liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and liver-Related Outcomes in Nonalcoholic Fatty liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
    Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
    Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gastroenteropancreatic neuroendocrine tumours: Clinicopathological evaluation at Shifa International Hospital, Islamabad.
    Mamoon N; Naveed H; Abid M; Nasir H; Ahmad IN; Hameed Z; Khan AH
    J Pak Med Assoc; 2021 Feb; 71(2(A)):492-496. PubMed ID: 33819235
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients.
    Liu K; Huang G; Chang P; Zhang W; Li T; Dai Z; Lv Y
    Sci Rep; 2020 Dec; 10(1):21376. PubMed ID: 33288828
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
    Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
    Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review.
    Cholongitas E; Mamou C; Rodríguez-Castro KI; Burra P
    Transpl Int; 2014 Oct; 27(10):1039-49. PubMed ID: 24943720
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk factors for the rising rates of primary liver cancer in the United States.
    El-Serag HB; Mason AC
    Arch Intern Med; 2000 Nov; 160(21):3227-30. PubMed ID: 11088082
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.